“Brentuximab Vedotin Effects on Prognosis of Refractory and Relapsed Peripheral T-Cell Lymphoma: A Systematic Review”. Revista De Medicina E Saúde De Brasília, vol. 7, no. 2, Jan. 2019, https://portalrevistas.ucb.br/index.php/rmsbr/article/view/9251.